ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
佰泽医疗
6.680
-0.370
-5.25%
手动刷新
成交量:
208.02万
成交额:
1,416.63万
市值:
88.04亿
市盈率:
-588.44
高:
7.060
开:
7.050
低:
6.670
收:
7.050
52周最高:
7.600
52周最低:
5.010
股本:
13.18亿
香港流通股本:
13.18亿
量比:
0.85
换手率:
0.16%
股息:
- -
股息率:
- -
每股收益(LYR):
-0.011
净资产收益率:
-0.30%
总资产收益率:
0.91%
市净率:
7.56
市盈率(LYR):
-588.44
市销率:
6.80
数据加载中...
总览
公司
新闻
公告
从并购整合到自主造血,佰泽医疗(02609)的扩张逻辑
智通财经
·
06/20
绿色经济(01315)附属对佰泽医疗所发行股份进行认购
智通财经
·
06/18
港股打新机会来了!四箭齐发,哪些值得一搏?资金如何规划?
格隆汇
·
06/14
【券商聚焦】国元国际:美国债市收益率下跌,关注新股市场
金吾财讯
·
06/13
新股招股 | 佰泽医疗6月13日至6月18日招股,入场费4090.85港元,引入Harvest Oriental为基石投资者
老虎资讯综合
·
06/13
佰泽医疗6月13日至6月18日招股 拟全球发售1.33亿股
金融界
·
06/13
佰泽医疗全球发售启动 股份最高发售价6.75港元
金融界
·
06/13
佰泽医疗全球发售启动 股份最高发售价6.75港元
观点机构
·
06/13
佰泽医疗(02609.HK)6月13日起招股 发售价每股4.22-6.75港元
格隆汇
·
06/13
一图解码:佰泽医疗过港交所聆讯 聚焦肿瘤医疗领域 收入稳增
IPO解码
·
06/11
曾经的黄金赛道成为弃子,佰泽医疗此时IPO凶多吉少?
财经自媒体
·
06/10
一周IPO观察:容大科技等3中小票等待上市,周六福、佰泽医疗、三花智控过讯,蜜雪布鲁可入港股通;Circle美股上市
FX168
·
06/09
24年扭亏为盈的“佰泽医疗”通过聆讯,拥有8家民营肿瘤医院
财华社
·
06/09
新股消息 | 佰泽医疗通过港交所聆讯 专注于提供肿瘤全周期医疗服务
智通财经
·
06/08
新股消息 | 佰泽医疗通过港交所聆讯 专注于提供肿瘤全周期医疗服务
智通财经网
·
06/08
民营肿瘤医疗集团“佰泽医疗”,递交IPO招股书,拟赴香港上市
新浪财经
·
06/07
佰泽医疗拟港股IPO,公司商誉较高
市场资讯
·
06/06
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02609/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02609","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02609\",,,,,undefined,":{"symbol":"02609","market":"HK","secType":"STK","nameCN":"佰泽医疗","latestPrice":6.68,"timestamp":1756195697319,"preClose":7.05,"halted":0,"volume":2080200,"delay":0,"floatShares":1318000000,"shares":1318000000,"eps":-0.011352,"marketStatus":"已收盘","change":-0.37,"latestTime":"08-26 16:08:17","open":7.05,"high":7.06,"low":6.67,"amount":14166285,"amplitude":0.055319,"askPrice":6.68,"askSize":8400,"bidPrice":6.67,"bidSize":7200,"shortable":0,"etf":0,"ttmEps":-0.011352,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":5,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":7.05,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.854867,"lotSize":600,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02609\",,,,,undefined,":{"symbol":"02609","floatShares":1318000000,"roa":"0.91%","roe":"-0.30%","lyrEps":-0.011352,"volumeRatio":0.854867,"shares":1318000000,"dividePrice":0,"high":7.06,"amplitude":0.055319,"preClose":7.05,"low":6.67,"week52Low":5.01,"pbRate":"7.56","psRate":"6.80","week52High":7.6,"institutionHeld":0,"latestPrice":6.68,"committee":-0.076923,"eps":-0.011352,"divideRate":0,"volume":2080200,"delay":0,"ttmEps":-0.011352,"open":7.05,"prevYearClose":4.22,"prevWeekClose":7.16,"prevMonthClose":6.49,"prevQuarterClose":6.17,"fiveDayClose":7.28,"twentyDayClose":6.37,"sixtyDayClose":4.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02609\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"02609","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02609\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02609\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02609\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02609","date":"2025-08-25","current":-632.308694,"percent":0.088889,"low":-655.144576,"twenty":-596.490791,"median":-582.715494,"eighty":-558.258755,"high":-492.081624,"avg":-581.693439,"sd":31.907323,"marketCap":9295191102},"quantilePoints":[{"date":"2025-06-20","current":-492.081624,"twenty":-492.081624,"median":-492.081624,"eighty":-492.081624,"marketCap":7231790524},{"date":"2025-06-27","current":-551.095341,"twenty":-551.095341,"median":-537.375124,"eighty":-524.87593,"marketCap":8121755629},{"date":"2025-07-04","current":-567.172112,"twenty":-564.18705,"median":-551.384774,"eighty":-534.620124,"marketCap":8359079657},{"date":"2025-07-11","current":-574.012485,"twenty":-568.540187,"median":-551.674207,"eighty":-537.566496,"marketCap":8451372335},{"date":"2025-07-18","current":-616.58395,"twenty":-577.068287,"median":-558.971658,"eighty":-540.54479,"marketCap":9071051742},{"date":"2025-07-25","current":-596.490791,"twenty":-589.259472,"median":-567.172112,"eighty":-548.775456,"marketCap":8807358377},{"date":"2025-08-01","current":-585.823371,"twenty":-589.259472,"median":-572.292685,"eighty":-551.007263,"marketCap":8596403685},{"date":"2025-08-08","current":-563.747633,"twenty":-590.513216,"median":-576.6281,"eighty":-551.558434,"marketCap":8293156316},{"date":"2025-08-15","current":-589.726565,"twenty":-590.186831,"median":-578.458416,"eighty":-556.915785,"marketCap":8662327027},{"date":"2025-08-22","current":-644.706974,"twenty":-595.216703,"median":-582.303123,"eighty":-558.25224,"marketCap":9440222452},{"date":"2025-08-25","current":-632.308694,"twenty":-596.490791,"median":-582.715494,"eighty":-558.258755,"marketCap":9295191102}],"updateTime":1756186964748},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02609\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544113003","title":"从并购整合到自主造血,佰泽医疗(02609)的扩张逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2544113003","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544113003?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 09:48","pubTimestamp":1750384122,"startTime":"0","endTime":"0","summary":"佰泽医疗将于6月23日正式于港交所主板挂牌上市。如今,这一模式正在佰泽医疗身上得到验证。从整体营收看,佰泽医疗营业收入从2022年的8亿元攀升至2024年的11.9亿元,实现21.7%的年均复合增长。2024年,佰泽医疗经营性净利润1249.6万元,实现扭亏为盈。作为肿瘤医疗集团,从肿瘤业务收入看,佰泽医疗2024年肿瘤业务收入同比增长10.87%,高于头部企业的9.1%。截至目前,佰泽医疗的商誉总额占公司资产比重仅为29.17%,低于行业头部公司的34.08%,在可控的合理范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1307559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02609"],"gpt_icon":1},{"id":"2544890869","title":"绿色经济(01315)附属对佰泽医疗所发行股份进行认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2544890869","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544890869?lang=zh_cn&edition=fundamental","pubTime":"2025-06-18 21:42","pubTimestamp":1750254145,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿色经济(01315)发布公告,于2025年6月18日,加华(本公司的全资附属公司,作为投资者)对佰泽医疗所发行股份进行认购,加华已同意按佰泽医疗于2025年6月13日发布的招股章程的条款认购由佰泽医疗将发行的投资者股份。加华就投资者股份应付的最高总认购价为1160万港元。本公司认为对佰泽医疗的投资将是一项良好的金融投资,因为本公司认为佰泽医疗的业务前景正面,且投资符合本集团的业务计划,将为股东及本集团带来投资收益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1306958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1148","01315","02609"],"gpt_icon":0},{"id":"2543663234","title":"港股打新机会来了!四箭齐发,哪些值得一搏?资金如何规划?","url":"https://stock-news.laohu8.com/highlight/detail?id=2543663234","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543663234?lang=zh_cn&edition=fundamental","pubTime":"2025-06-14 15:42","pubTimestamp":1749886937,"startTime":"0","endTime":"0","summary":"胜率结合赔率","market":"us","thumbnail":"https://img2.gelonghui.com/42e3b-b7d220fb-1e34-4762-b49a-755b1921c7c1.png?guru_height=847&guru_width=1216","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/42e3b-b7d220fb-1e34-4762-b49a-755b1921c7c1.png?guru_height=847&guru_width=1216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2328526","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4614","03288","HSCEI","02050","HSTECH","02609","YANG"],"gpt_icon":1},{"id":"2543578068","title":"【券商聚焦】国元国际:美国债市收益率下跌,关注新股市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2543578068","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543578068?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 10:46","pubTimestamp":1749782809,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国元国际发布研报指,美国5月核心PPI同比+3%、环比+0.1%,均不及预期;上周初请失业金人数为24.8万高于预期。美国商务部宣布将自6月23日起对多种钢制家用电器加征关税。美国5月海运进口骤降,印度航空一架波音787客机坠毁,英国经济出现18个月来最严重萎缩。研报指出,2年期美债收益率跌5个基点报3.897%,5年期美债收益率跌5.6个基点报3.961%,10年期美债收益率跌6.11个基点报4.359%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1960417","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","09141","02609","02050"],"gpt_icon":0},{"id":"1175243828","title":"新股招股 | 佰泽医疗6月13日至6月18日招股,入场费4090.85港元,引入Harvest Oriental为基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=1175243828","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175243828?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 08:39","pubTimestamp":1749775157,"startTime":"0","endTime":"0","summary":"$佰泽医疗$ 于2025年6月13日至6月18日招股,拟全球发售1.33亿股,其中香港发售占约10%,国际发售占约90%。每股发售价4.22-6.75港元,每手600股,入场费4090.85港元,预期股份将于2025年6月23日(星期一)上午九时正开始在联交所买卖。集团已与Harvest Oriental订立基石投资协议,基石投资者已同意在满足若干条件的情况下认购或购买发售股份,数目为按发售价以总金额约为1900万美元可购入的数目。假设发售价为5.49港元,基石投资者将认购的发售股份总数为2714.76万股股份。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/78d1a91f9d8e17959d4ee550b79de399","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/78d1a91f9d8e17959d4ee550b79de399"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股招股 | 佰泽医疗今起招股,入场费4090.85港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"gpt_icon":1},{"id":"2543296695","title":"佰泽医疗6月13日至6月18日招股 拟全球发售1.33亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2543296695","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543296695?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 08:29","pubTimestamp":1749774563,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K1TVEAM50519QIKK.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K1TVEAM50519QIKK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02609"],"gpt_icon":0},{"id":"2543525477","title":"佰泽医疗全球发售启动 股份最高发售价6.75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543525477","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543525477?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 07:56","pubTimestamp":1749772575,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K1TTHL7O0519QIKK.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K1TTHL7O0519QIKK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02609"],"gpt_icon":0},{"id":"2543525384","title":"佰泽医疗全球发售启动 股份最高发售价6.75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543525384","media":"观点机构","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543525384?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 07:35","pubTimestamp":1749771306,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K1TSAU6O0519D45U.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K1TSAU6O0519D45U.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02609"],"gpt_icon":0},{"id":"2543523564","title":"佰泽医疗(02609.HK)6月13日起招股 发售价每股4.22-6.75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543523564","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543523564?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 06:46","pubTimestamp":1749768396,"startTime":"0","endTime":"0","summary":"格隆汇6月13日丨佰泽医疗(02609.HK)发布公告,公司拟全球发售约1.33亿股股份,中国香港发售股份1331.1万股,国际发售股份约1.20亿股;2025年6月13日至6月18日招股,预期定价日为6月19日;发售价将为每股发售股份4.22-6.75港元,每手买卖单位为600股,招银国际为独家保荐人;预期股份将于2025年6月23日开始在联交所买卖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/13064651036572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159891","02609"],"gpt_icon":0},{"id":"2542373339","title":"一图解码:佰泽医疗过港交所聆讯 聚焦肿瘤医疗领域 收入稳增","url":"https://stock-news.laohu8.com/highlight/detail?id=2542373339","media":"IPO解码","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542373339?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 10:54","pubTimestamp":1749610465,"startTime":"0","endTime":"0","summary":"佰泽医疗是中国主要从事投资及提供医疗相关服务的肿瘤医疗集团。具体而言,佰泽医疗是“肿瘤全周期医疗服务”领域的服务供应商,筛查、诊断、治疗及康复是其在肿瘤全周期医疗服务体系中提供的核心服务。随着其快速发展和扩张,佰泽医疗于业绩记录期间的运营能力增强。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611105535a702f9cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611105535a702f9cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YR35.GBP","LU1734074674.USD","LU1807302812.USD","SG9999002463.SGD","LU0348827113.USD","LU0501845795.SGD","LU0149721374.USD","LU0650527681.SGD","LU0516422440.USD","LU0314109678.HKD","LU1282649810.SGD","LU1366334578.USD","LU0607220059.USD","LU0873338254.USD","LU0384037296.USD","IE00B3T34201.USD","LU0594300419.USD","HEXmain","02609","LU0762542818.HKD","LU0516423174.USD","LU0762540952.USD","LU0630378429.USD","LU1282648689.USD","LU0048597586.USD","BK1589","LU0164880469.USD","LU0165289439.USD","LU0605514214.HKD","LU1044875133.USD","LU0149534421.HKD","LU1981816686.USD","00388","LU0061477393.USD","LU0561508036.HKD","LU0197773673.USD","80388","LU0979878070.USD","LU0791591158.USD","LU1044876610.USD","LU1328277881.USD","LU0251144936.SGD","LU1481107354.HKD","LU0516422952.EUR","LU0762541174.USD","LU0898667661.SGD","LU0043850808.USD","HKXCY","IE00BKZH1Z71.USD","IE00BZ08YS42.EUR","LU1044874839.SGD"],"gpt_icon":1},{"id":"2542395423","title":"曾经的黄金赛道成为弃子,佰泽医疗此时IPO凶多吉少?","url":"https://stock-news.laohu8.com/highlight/detail?id=2542395423","media":"财经自媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542395423?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 15:50","pubTimestamp":1749541800,"startTime":"0","endTime":"0","summary":"相比另一家肿瘤医院龙头海吉亚医疗,佰泽医疗没有明确的品牌策略,而海吉亚医疗则在各地开设海吉亚医院,品牌命名一脉相承:虽然佰泽医疗属于“杂牌军”,但当下港股IPO市场火爆,今日上市的荣大科技和新琪安双双大涨。因此,如果佰泽医疗IPO市值在20亿及以下,或有利可图,如果定价较高,恐怕只有情绪价值,基本面难以支撑。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-06-10/doc-inezqruh0232638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GCmain","1OZmain","SGUmain","159831","NUGT","IAU","GDX","MGCmain","SGCmain","159934","518880","159891","02609","DUST"],"gpt_icon":1},{"id":"2542803271","title":"一周IPO观察:容大科技等3中小票等待上市,周六福、佰泽医疗、三花智控过讯,蜜雪布鲁可入港股通;Circle美股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2542803271","media":"FX168","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542803271?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 11:18","pubTimestamp":1749439119,"startTime":"0","endTime":"0","summary":"截止2025年的第23周,港交所无家新股上市,3家招股,4家通过聆讯,4家递交招股书。$蜜雪集团$ 、 $古茗$ 、 $布鲁可$ ,于6月9日正式纳入港股通。6月3日,周六福在港交所披露聆讯后的招股书,或很快在香港主板挂牌上市,联席保荐人为中金和中信建投。截至2024年12月31日,手回科技累计投保人数量超过350万,累计被保险人数超过580万。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fx168news.com/article/896844","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","002050","LU1064131003.USD","LU1328615791.USD","LU0359202008.SGD","BK0197","LU0359201612.USD","02609","LU1939255532.USD","BK0259","LU2298064838.USD","YANG","LU2238339852.HKD","LU2580892789.USD","BK4614","BK0070","BK0076","LU2148510915.USD","159891","06168","BK1213","02050","LU2580892862.HKD","HSTECH","SGXZ49509284.SGD","LU1969619763.USD","LU1023057109.AUD","BK0187","SGXZ81163826.USD","LU0211977185.USD","BK0028","LU2328871848.SGD","09881","LU1064130708.USD"],"gpt_icon":1},{"id":"2542875191","title":"24年扭亏为盈的“佰泽医疗”通过聆讯,拥有8家民营肿瘤医院","url":"https://stock-news.laohu8.com/highlight/detail?id=2542875191","media":"财华社","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542875191?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 09:24","pubTimestamp":1749432273,"startTime":"0","endTime":"0","summary":"摘要:佰泽医疗于2025年6月6日通过港交所聆讯,即将在香港主板上市,独家保荐人为招银国际。公司是中国领先的主要从事投资及提供医疗相关服务的肿瘤医疗集团。2024年收入约11.89亿人民币,同比增长10.88%,经调整净利约0.12亿人民币,扭亏为盈。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202506_1/01189a98-fcc2-4f05-b3f9-e175d794e4b6.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202506_1/01189a98-fcc2-4f05-b3f9-e175d794e4b6.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/684637d1230829ee40bd288d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["02609","BK1193","03396","BK1607"],"gpt_icon":0},{"id":"2541846397","title":"新股消息 | 佰泽医疗通过港交所聆讯 专注于提供肿瘤全周期医疗服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2541846397","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541846397?lang=zh_cn&edition=fundamental","pubTime":"2025-06-08 07:32","pubTimestamp":1749339153,"startTime":"0","endTime":"0","summary":"据招股书,佰泽医疗是“肿瘤全周期医疗服务”领域的服务供货商,筛查、诊断、治疗及康复是该公司在肿瘤全周期医疗服务体系中提供的核心服务。截至最后实际可行日期,佰泽医疗通过于六家民营营利性医院的直接股权所有权及两家民营非营利性医院的管理权,在北京、天津、山西省、安徽省及河南省运营和管理八家医院,专注于提供肿瘤全周期医疗服务。佰泽医疗于业绩记录期间实现了显著增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506080744169775ec22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506080744169775ec22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0164880469.USD","LU0648948544.HKD","LU0561508036.HKD","LU0979878070.USD","LU1813983027.USD","SG9999002463.SGD","LU0061477393.USD","LU1734074674.USD","LU2449936058.SGD","LU0607220059.USD","LU0516423091.SGD","LU1226287529.USD","LU0067412154.USD","LU0417516738.SGD","80388","LU0898667661.SGD","LU1981816686.USD","IE00BKZH1Z71.USD","LU0873338254.USD","SG9999001093.SGD","LU0650527681.SGD","LU0791591158.USD","LU0140636845.USD","02609","LU0577902611.USD","LU0165289439.USD","LU0577902298.EUR","HEXmain","LU0348735423.USD","IE00BZ08YR35.GBP","LU0572944931.SGD","LU0594300179.USD","LU2257852520.SGD","LU0370786039.SGD","LU0540923850.HKD","LU0577902371.SGD","LU2226246903.HKD","LU0886674414.USD","LU0348827113.USD","LU1328277881.USD","LU0043850808.USD","HKXCY","LU0605514214.HKD","LU1044875133.USD","LU1044876610.USD","00388","IE00BZ08YT58.USD","LU0149534421.HKD","LU1366334578.USD","LU0797268264.HKD","IE00BZ08YS42.EUR"],"gpt_icon":1},{"id":"2541846313","title":"新股消息 | 佰泽医疗通过港交所聆讯 专注于提供肿瘤全周期医疗服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2541846313","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541846313?lang=zh_cn&edition=fundamental","pubTime":"2025-06-08 07:32","pubTimestamp":1749339153,"startTime":"0","endTime":"0","summary":"据招股书,佰泽医疗是“肿瘤全周期医疗服务”领域的服务供货商,筛查、诊断、治疗及康复是该公司在肿瘤全周期医疗服务体系中提供的核心服务。截至最后实际可行日期,佰泽医疗通过于六家民营营利性医院的直接股权所有权及两家民营非营利性医院的管理权,在北京、天津、山西省、安徽省及河南省运营和管理八家医院,专注于提供肿瘤全周期医疗服务。佰泽医疗于业绩记录期间实现了显著增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1302596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["159891","02609"],"gpt_icon":0},{"id":"2541813775","title":"民营肿瘤医疗集团“佰泽医疗”,递交IPO招股书,拟赴香港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2541813775","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541813775?lang=zh_cn&edition=fundamental","pubTime":"2025-06-07 13:41","pubTimestamp":1749274876,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K1F2T3D105568W0A.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K1F2T3D105568W0A.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02609"],"gpt_icon":0},{"id":"2541854869","title":"佰泽医疗拟港股IPO,公司商誉较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2541854869","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541854869?lang=zh_cn&edition=fundamental","pubTime":"2025-06-06 16:33","pubTimestamp":1749198780,"startTime":"0","endTime":"0","summary":"5月16日,佰泽医疗获证监会备案,拟发行不超过2.41亿股境外上市普通股并在香港联合交易所上市。佰泽医疗表示,2021年、2022年、2023年及2024年上半年,公司分别形成商誉5.075亿元、6.43亿元、6.43亿元及6.43亿元,主要来自公司于业绩记录期间收购的医院。招股书显示,2021年至2024年12月4日,为解决医疗纠纷,公司自有医院支付的赔偿总额约为220万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-06-06/doc-inezcrkc7313651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02609","HSTECH","159891","YANG","BK4614"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":57,"code":"91000000","status":"200"}]}}